期刊文献+

致病性鸡大肠杆菌pilA和外膜蛋白C原核诱导表达条件的优化 被引量:1

Optimized Expression of pliA and ompC from Avian Pathogenic Escherichia coli
下载PDF
导出
摘要 分别从温度、接菌量、诱导时机、IPTG浓度、诱导时间等条件对2种重组菌株BL21/pET-28a-pilA和BL21/pET-28a-ompC进行优化.得到最佳诱导条件:BL21/pET-28a-pilA菌株为40℃摇培,80μL的接菌量,160 r/min摇培2 h后加入终浓度为0.96 mmol/L的IPTG,再诱导表达4 h,得到最高特异蛋白表达量;BL21/pET-28a-ompC菌株为37℃培养,80μL的接菌量,160 r/min摇培2.5 h后加入终浓度为0.64 mmol/L的IPTG,再诱导表达6 h,得到最高特异蛋白表达量. Type Ⅰ piliA of avian pathogenic E. coli was a very important pathogenic factor. E. coli outer membrane protein had nicer immunogenicity and it played an important role in maintaining the form of bacteria, metabolism and immunity. The optimum conditions of induction from the temperature, amount of bacteria, induction opportunity, IPTG concentration and induction time in BL21/pET-28a-pilA and BL21/pET-28a-ompC were explored. The best condition of BL21/pET-28a-pilA was 40 ℃,80 μL was effective amount,shaking 2 h and then pipette IPTG into cuvettetests to make a final concentration of 0.96 mmol/L, and another 4h induction. The best condition of BL21/pET-28a-ompC was 37 ℃ , 80 μL was effective amount, shaking 2.5 h and then pipette IPTG into cuvettetests to make a final concentration of 0.64 mmol/L, and another 6 h induction. Thus, the highest expression levels of specific proteins were obtained.
出处 《河北师范大学学报(自然科学版)》 CAS 北大核心 2009年第5期671-676,共6页 Journal of Hebei Normal University:Natural Science
基金 河北省科技攻关项目(012201130)
关键词 pilA OMPC 原核表达 诱导条件优化 pilA ompC prokaryotic expression optimum condition
  • 相关文献

参考文献10

二级参考文献94

共引文献34

同被引文献20

  • 1赵春丽,范秀军,赵冰,于洋,李庆章,郝艳红.IPTG诱导浓度对重组人肝再生增强因子基因表达的影响[J].东北农业大学学报,2004,35(4):441-445. 被引量:11
  • 2金元昌,刘利,苏晓艳,李景鹏,李会东,周建红.IPTG诱导浓度、时间及温度对重组促性腺激素释放激素基因表达的影响[J].黑龙江畜牧兽医,2006(8):17-19. 被引量:7
  • 3KORHONEN H, PIHLANTO A. Bioactive peptides: production and functionality[J]. International Dairy Journal, 2006, 16(9): 945-960.
  • 4HADDEN J W. Immunotherapy of human immunodeficiency virus infection[J]. Trends in Pharmacological Sciences, 1991, 12: 107- 111.
  • 5LOSACCO M, GALLERANI R, GOBBETTI M, et al. Production of active angiotensin-I converting enzyme inhibitory peptides derived from bovine β-casein by recombinant DNA technologies[J]. Biotechnology Journal, 2007, 2(11): 1425-1434.
  • 6GILL H, DOULL F, RUTHERFURD K, et al. Immunoregulatory peptides in bovine milk[J]. British Journal of Nutrition, 2007, 84(Suppl 1): 111-117.
  • 7BERTHOU J, MIGLIORE-SAMOUR D, LIFCHITZ A, et al. Immunostimulating properties and three-dimensional structure of two tripeptides from human and cow caseins[J]. FEBS Letters, 1987, 218(1): 55-58.
  • 8PAUS R. Therapeutic strategies for treating hair loss[J]. Drug Discovery Today: Therapeutic Strategies, 2006, 3(1): 101-110.
  • 9JOLLES P, MIGLORE-SAMOUR D, PARKER F. Immuno stimulant substances derived from bovine casein and compositions containing the same: United States, US4777243[P]. 1988-10-11.
  • 10TULER T, CALLANAN M, KLAENHAMMER T. Overexpression of peptidases in Lactococcus and evaluation of their release from leaky cells [J]. Journal of Dairy Science, 2002, 85(10): 2438-2450.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部